Pardanani, A
Abdelrahman, R A
Finke, C
Lasho, T T
Begna, K H
Al-Kali, A
Hogan, W J
Litzow, M R
Hanson, C A
Ketterling, R P
Tefferi, A
Article History
First Online: 11 November 2014
Competing interests
: AT was Principal Investigator for studies CCL09101 and CCL09101E for the Mayo Clinic (Rochester) site. AP and AT are/have served as Principal Investigator for other JAK inhibitor clinical trials for myelofibrosis treatment. The remaining authors declare no conflict of interest.